Several studies reported the effectiveness of PD‐1 inhibitors such as nivolumab,6, 28 pembrolizumab,3, 29 and CTLA4 inhibitors (ipilimumab)3 in treating pediatric brain tumors associated with CMMRD. The gene discussed is PDCD1; the disease is brain neoplasm.